Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1950 1
1952 1
1954 1
1955 1
1956 1
1957 2
1960 1
1961 1
1962 2
1963 2
1964 4
1965 1
1966 1
1968 2
1969 4
1970 5
1971 1
1972 6
1973 5
1974 5
1975 5
1976 4
1977 1
1978 4
1979 10
1980 7
1981 7
1982 9
1983 3
1984 11
1985 15
1986 15
1987 8
1988 6
1989 17
1990 13
1991 12
1992 14
1993 23
1994 14
1995 23
1996 12
1997 20
1998 16
1999 17
2000 22
2001 33
2002 30
2003 28
2004 51
2005 45
2006 45
2007 67
2008 76
2009 88
2010 67
2011 79
2012 84
2013 58
2014 74
2015 84
2016 79
2017 88
2018 72
2019 85
2020 114
2021 103
2022 83
2023 82
2024 85

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,885 results

Results by year

Filters applied: . Clear all
Page 1
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer.
Schettini F, Chic N, Brasó-Maristany F, Paré L, Pascual T, Conte B, Martínez-Sáez O, Adamo B, Vidal M, Barnadas E, Fernández-Martinez A, González-Farre B, Sanfeliu E, Cejalvo JM, Perrone G, Sabarese G, Zalfa F, Peg V, Fasani R, Villagrasa P, Gavilá J, Barrios CH, Lluch A, Martín M, Locci M, De Placido S, Prat A. Schettini F, et al. Among authors: vidal m. NPJ Breast Cancer. 2021 Jan 4;7(1):1. doi: 10.1038/s41523-020-00208-2. NPJ Breast Cancer. 2021. PMID: 33397968 Free PMC article.
TIGAR, a p53-inducible regulator of glycolysis and apoptosis.
Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH. Bensaad K, et al. Among authors: vidal mn. Cell. 2006 Jul 14;126(1):107-20. doi: 10.1016/j.cell.2006.05.036. Cell. 2006. PMID: 16839880 Free article.
Proteome-Scale Human Interactomics.
Luck K, Sheynkman GM, Zhang I, Vidal M. Luck K, et al. Among authors: vidal m. Trends Biochem Sci. 2017 May;42(5):342-354. doi: 10.1016/j.tibs.2017.02.006. Epub 2017 Mar 8. Trends Biochem Sci. 2017. PMID: 28284537 Free PMC article. Review.
Refractory fibromyalgia.
Vidal LF, Messina O, Rodríguez T, Vidal M, Pineda C, Morales R, Collado A. Vidal LF, et al. Among authors: vidal m. Clin Rheumatol. 2021 Sep;40(9):3853-3858. doi: 10.1007/s10067-021-05818-0. Epub 2021 Jun 24. Clin Rheumatol. 2021. PMID: 34169373 Review.
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer.
Villacampa G, Tung NM, Pernas S, Paré L, Bueno-Muiño C, Echavarría I, López-Tarruella S, Roche-Molina M, Del Monte-Millán M, Marín-Aguilera M, Brasó-Maristany F, Waks AG, Pascual T, Martínez-Sáez O, Vivancos A, Conte PF, Guarneri V, Vittoria Dieci M, Griguolo G, Cortés J, Llombart-Cussac A, Muñoz M, Vidal M, Adamo B, Wolff AC, DeMichele A, Villagrasa P, Parker JS, Perou CM, Fernandez-Martinez A, Carey LA, Mittendorf EA, Martín M, Prat A, Tolaney SM. Villacampa G, et al. Among authors: vidal m. Ann Oncol. 2023 Sep;34(9):783-795. doi: 10.1016/j.annonc.2023.05.012. Epub 2023 Jun 9. Ann Oncol. 2023. PMID: 37302750 Free PMC article.
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis.
Schettini F, Pascual T, Conte B, Chic N, Brasó-Maristany F, Galván P, Martínez O, Adamo B, Vidal M, Muñoz M, Fernández-Martinez A, Rognoni C, Griguolo G, Guarneri V, Conte PF, Locci M, Brase JC, Gonzalez-Farre B, Villagrasa P, De Placido S, Schiff R, Veeraraghavan J, Rimawi MF, Osborne CK, Pernas S, Perou CM, Carey LA, Prat A. Schettini F, et al. Among authors: vidal m. Cancer Treat Rev. 2020 Mar;84:101965. doi: 10.1016/j.ctrv.2020.101965. Epub 2020 Jan 17. Cancer Treat Rev. 2020. PMID: 32000054 Free PMC article.
A proteome-scale map of the SARS-CoV-2-human contactome.
Kim DK, Weller B, Lin CW, Sheykhkarimli D, Knapp JJ, Dugied G, Zanzoni A, Pons C, Tofaute MJ, Maseko SB, Spirohn K, Laval F, Lambourne L, Kishore N, Rayhan A, Sauer M, Young V, Halder H, la Rosa NM, Pogoutse O, Strobel A, Schwehn P, Li R, Rothballer ST, Altmann M, Cassonnet P, Coté AG, Vergara LE, Hazelwood I, Liu BB, Nguyen M, Pandiarajan R, Dohai B, Coloma PAR, Poirson J, Giuliana P, Willems L, Taipale M, Jacob Y, Hao T, Hill DE, Brun C, Twizere JC, Krappmann D, Heinig M, Falter C, Aloy P, Demeret C, Vidal M, Calderwood MA, Roth FP, Falter-Braun P. Kim DK, et al. Among authors: vidal m. Nat Biotechnol. 2023 Jan;41(1):140-149. doi: 10.1038/s41587-022-01475-z. Epub 2022 Oct 10. Nat Biotechnol. 2023. PMID: 36217029 Free PMC article.
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
Brasó-Maristany F, Griguolo G, Chic N, Pascual T, Paré L, Maues J, Galván P, Dieci MV, Miglietta F, Giarratano T, Martínez-Sáez O, Marín-Aguilera M, Schettini F, Conte B, Angelats L, Vidal M, Adamo B, Muñoz M, Sanfeliu E, González B, Vivancos A, Villagrasa P, Parker JS, Perou CM, Conte P, Prat A, Guarneri V. Brasó-Maristany F, et al. Among authors: vidal m. J Natl Cancer Inst. 2023 Mar 9;115(3):332-336. doi: 10.1093/jnci/djac227. J Natl Cancer Inst. 2023. PMID: 36576009 Free PMC article.
Osteoporosis: a clinical and pharmacological update.
Vidal M, Thibodaux RJ, Neira LFV, Messina OD. Vidal M, et al. Clin Rheumatol. 2019 Feb;38(2):385-395. doi: 10.1007/s10067-018-4370-1. Epub 2018 Dec 12. Clin Rheumatol. 2019. PMID: 30542797 Review.
High-risk abdominal pediatric paraganglioma.
Poumeaud F, Duval M, Gambart M, O Dierickx L, Abbo O, Hangard G, Doyen J, Vidal M, Aubert S, Carillo F, Mouly C, Vial J, Gomez-Brouchet A, Laprie A. Poumeaud F, et al. Among authors: vidal m. Pediatr Blood Cancer. 2023 Jan;70(1):e29834. doi: 10.1002/pbc.29834. Epub 2022 Aug 15. Pediatr Blood Cancer. 2023. PMID: 35731232 No abstract available.
1,885 results